12th June 2020 Content supplied by: TBG Biotechnology Corp
TBG's COVID-19 Test Portfolio Now Includes Rapid Antibody & FDA-EUA qPCR Kits
TBG Biotechnology has received US FDA Emergency Use Authorization for its ExProbe™ SARS-CoV-2 Testing Kit to detect SARS-CoV-2, the virus that causes COVID-19. The qPCR kit has already received CE-marking for use in Europe.
ExProbeTM SARS-CoV-2 Testing Kit is a real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal aspirate/wash and nasal aspirate specimens, and bronchoalveolar lavage (BALs) specimens from individuals suspected of COVID-19 by their healthcare provider.
The ExProbeTM SARS-CoV-2 Testing Kit uses dual-labelled probes that target a distinct region in the RdRP gene of the SARS-CoV-2 genome and one region in both the N and E genes of Sarbecovirus as well as SARS-CoV-2.
- Four colour multiplex to detect RdRP, N, E and internal control
- LOD of 50 copies/reaction
- Automation setup for high throughput
- Kit Contents: PCR mix, enzyme mix, pos/neg controls, and IFU.
- Storage: -20±5°C for six months.
- Compatible: ABI7500 and TBG Q6000 real-time PCR system (Source: www.tbgbio.com/qPCR)
TBG Biotechnology has also developed the SARS-CoV-2 IgG/IgM Rapid Test Kit, which is now CE-IVD certified. The SARS-CoV-2 IgG/IgM Rapid Test Kit is used to qualitatively detect IgG and IgM antibodies of SARS-CoV-2 in human serum, plasma or whole blood. This device is intended to be used by professionals as a screening test and for SARS-CoV-2 research. Any reactive specimen with the SARS-CoV-2 IgG/IgM rapid test kit should be confirmed with alternative testing method(s).
Features & Benefits
- Easy to Use with only 3 steps
- Fast Results within 15 minutes
- High Sensitivity with both N and S antigen-coated (Source: www.tbgbio.com/antibody)
WATCH: Introductory Video of TBG Biotechnology's COVID-19 Test Kits
If you would like to contact TBG Biotechnology for further information, please use the 'Request Information' button provided below.
Date Published: 12th June 2020
Source article link: View